São Paulo - Delayed Quote BRL

Clover Health Investments, Corp. (CLOV34.SA)

4.5400 -0.4000 (-8.10%)
At close: May 17 at 10:33 AM GMT-3
Loading Chart for CLOV34.SA
DELL
  • Previous Close 4.9400
  • Open 0.0000
  • Bid 4.3500 x --
  • Ask 9.1800 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 7.7200
  • Volume 0
  • Avg. Volume 352
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -7.2980
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: CLOV34.SA

Performance Overview: CLOV34.SA

Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV34.SA
0.00%
MSCI WORLD
9.64%

1-Year Return

CLOV34.SA
14.50%
MSCI WORLD
22.23%

3-Year Return

CLOV34.SA
61.66%
MSCI WORLD
18.09%

5-Year Return

CLOV34.SA
61.66%
MSCI WORLD
18.09%

Compare To: CLOV34.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV34.SA

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.77%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.06B

  • Net Income Avi to Common (ttm)

    -156.83M

  • Diluted EPS (ttm)

    -7.2980

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    1.63%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CLOV34.SA

Company Insights: CLOV34.SA

Research Reports: CLOV34.SA